Oncology - European Medical Journal

Continue

Oncology

Filter
10 Mins
24 Oct 2023

Recent Developments in Endometrial Cancer Research Presented at the Society of Gynecologic Oncology (SGO) Annual Meeting 2023: Interviews with Two Key Opinion Leaders

Endometrial cancer is the most common gynaecological malignancy in developed countries, and often presents at an early stage. Paclitaxel…
8 Mins
12 Oct 2023

Effects of Obesity on Cancer Prognosis and Treatment

Obesity, defined as a BMI greater than or equal to 30 kg/m2, is a condition with rising incidence around the world that contributes…
11 Mins
2 Oct 2023

Real-World Evidence of Biosimilar Utilisation and Pharmacoeconomics in People Living with Breast or Lung Cancer

As the medical community continues to explore and harness the potential of biosimilars, it is imperative to accumulate robust real-world…
6 Mins
25 Aug 2023

Interview: Karen Canfell

My entry point was through a field that I now still spend a lot of time in, which is cervical cancer control…
7 Mins
7 Aug 2023

PTEN Loss causing Dabrafenib and Trametinib Resistance in Epithelioid Glioblastoma

This case report explores a rare and aggressive variant of glioblastoma that is common in children and young adults…
8 Mins
26 Jul 2023

Interview: Kelly Hirko

My interest in cancer research was sparked during my experience in the Undergraduate Research Opportunity Program (UROP) as an…
10 Mins
16 Mar 2023

The Role of Granulocyte-Colony Stimulating Factor Biosimilars for Supportive Cancer Care: A Year in Review

Chemotherapy-induced neutropenia is a frequent, severe, adverse haematological complication of myelosuppressive and immunosuppressive cytotoxic chemotherapy treatment.
11 Mins
14 Feb 2023

A Review of the Latest Advancements in Ovarian Cancer Care Featured at ESMO 2022

Ovarian cancer is the seventh most commonly diagnosed cancer among females and the most lethal gynaecologic malignancy globally because of its vague presentation, insidious nature, recurrence, and drug resistance.